Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Nereid Therapeutics

Request full access

A pioneer of the biomolecular condensate field and one of the world’s leading experts in intracellular liquid-liquid phase separation

Boston, United StatesFounded 2020Biotech & Life Sciences

About Nereid Therapeutics

Nereid Therapeutics is a biotechnology startup that operates in the field of intracellular liquid-liquid phase separation (LLPS), a process similar to the movement of a lava lamp. This process occurs within living cells and plays a crucial role in gene regulation and various disease processes. Nereid's work is based on the pioneering research of its academic founder, Clifford Brangwynne, Ph.D., a leading expert in the field of biomolecular condensate.

Nereid's business model revolves around the development and application of technologies that can measure and influence LLPS in mammalian cells. The company uses advanced microscopy and computer vision to observe the formation and behavior of membrane-less droplets within cells, which are key to the LLPS process. By understanding and manipulating these droplets, Nereid aims to discover small molecules that can alter protein interactions associated with diseases.

The company's primary market is the healthcare sector, specifically in the development of treatments for intractable diseases such as cancers, neurodegenerative illnesses, and inflammatory disorders. Nereid's approach combines soft matter physics and cell biology, using machine learning to enhance insights and accelerate the translation of these insights into medicinal chemistry.

In terms of revenue generation, Nereid likely operates on a business-to-business model, partnering with larger pharmaceutical companies to develop and commercialize its discoveries. The company's unique approach to disease treatment could potentially offer a new avenue for the development of therapeutics, making it an attractive partner for larger entities in the pharmaceutical industry.

Source: Dealroom company data

At a glance

Status
Operational
Employees
2
Open positions
None listed
Dealroom signal
58.2/100
Industry
Health
Sub-industry
BioTechnology
Sector
Biotechnology, Spinout, Biotech and Pharma, proteomics, DT and LS, science-based
Business model
Manufacturing
Client focus
B2B

Funding history

2 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES AOther financing Nov 2020 $50M $200M Clifford P. Brangwynne · Apple Tree Partners —
SPINOUTOther financing Jan 2020 $0 — Princeton University —
Showing the latest 2 of 2 recorded eventsBook a demo for the full funding history →

Growth signals

Nereid Therapeutics website traffic

Latest recorded traffic for Nereid Therapeutics is 2K monthly website visits, down 16.7% over the last three months. Nereid Therapeutics's team declined 60% over the past year.

Latest monthly visits2K 3-month web change-16.7% 1-year team growth-60%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Nereid Therapeutics in the Boston ecosystem

Live from Dealroom

The Nereid Therapeutics office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

3 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A2 investors entered at this stage

  • Apple Tree Partners
  • Clifford P. Brangwynne

Other known investors1 additional known investor

  • Princeton University
Team profiled 3 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 2 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
1 countries with
team presence
🇺🇸 United States100%
1 country shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Nereid Therapeutics on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Nereid Therapeutics’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.